Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer
This cohort study examines the risk of mortality in men with vs without breast cancer–specific mortality.
This cohort study examines the risk of mortality in men with vs without breast cancer–specific mortality.
Novel tissue-agnostic therapeutics targeting driver mutations in tumor cells have been recently approved by FDA, driven by basket trials that have demonstrated their efficacy and…
This Medical News article discusses the current H5N1 avian influenza outbreak in US dairy cattle and its implications for occupational and public health.
PURPOSE Human epidermal growth factor receptor 2 (HER2) is an effective therapeutic target in breast and gastric and gastroesophageal junction cancers. However, less is known…
PURPOSE To study whether BRAF V600 mutations in non–small-cell lung cancer (NSCLC) may indicate sensitivity to the BRAF inhibitor vemurafenib, we included a cohort of…
Purpose Parallel activation of the phosphatidylinositol 3-kinase–mammalian target of rapamycin pathway represents a mechanism of primary and acquired resistance to BRAF-targeted therapy, but the two…
One to two percent of non–small-cell lung cancers (NSCLCs) harbor ROS1 gene rearrangements. 1 – 3 ROS1 gene rearrangement leads to constitutive activation receptor tyrosine…
Solid pseudopapillary neoplasms (SPNs) of the pancreas are exocrine neoplasms that predominantly affect young females and are considered to have low malignant potential. Surgical resection…
Financial support: Jie Wu, Jie Wu Administrative support: Vivek Subbiah, Vivek Subbiah Provision of study materials or patients: Sireesha Yedururi, Vivek Subbiah, Sireesha Yedururi, Vivek…
Medullary thyroid cancer (MTC) is a neuroendocrine tumor that originates from the parafollicular cells (or C cells) of the thyroid gland and account s for…